Amarin Corporation plc Message Board
- Reply to
Amarin Reports Solid Vascepa TRx Growth /// LINKED
by terridiamond158 •May 17, 2013 3:23 PMLONG.
- Reply to
With NCE Out of The Way, Will Go Back to $8 On Increased Sales
by terridiamond158 •May 17, 2013 4:19 PMtrend has been going straight up, uncertainty with NCE took it lower for great entry point. Now that is over straight back up and great sales.
- Reply to
High LDL Leads to Heart Attacks * Lovaza RAISES LDL 45% * Vascepa Lowers LDL
by tradinghulkman •May 17, 2013 5:20 PMLDL is THE most important levels. You want your LDL Low so you are NOT at risk of heart failure or heart attack. No Dr. is going to give Lovaza, now that there is Vascepa.
- Reply to
Article Says "AMRN Average PT is $17.65 / AMRN Very Undervalued ". LINKED
by larrystone13 •9 hours agoGood Link. Nice DD.
-
sales going to grow fast now.
-
samayc09== No offense but you shouldn't be trading. BASF is a Supplier for AMRN Not any form of competition./ Wow do your DD man.
- Reply to
Biotech's Next Big Thing ASCO II " HALO to be Big ASCO Winner This Year. " /// post.
by fromnyjohn •May 16, 2013 2:41 PMAdam F. --Smart Man.
-
Sales already proving that. Do the DD, Vascepa is a superior drug.
-
sqeeze to begin.
- Reply to
LINK : CEO " Documents Requested by FDA Will Be Submitted ThIS Month " link
by drmiller355 •May 9, 2013 12:16 PMshould have them next week.
-
- Reply to
Mon is Already the Middle of May. FDA will have documents shortly after.
by going1green •May 10, 2013 2:43 PMin and long
- Reply to
Mon is Already the Middle of May. FDA will have documents shortly after.
by going1green •May 10, 2013 2:43 PMin and long
- Reply to
Call Says FDA Decision Made When Receive Documents, No Meeting.... read
by mdollarsigns •May 10, 2013 10:24 AMI thin it also be great to let everyone think AA in June and then it comes in May..no meeting scheduled per call.
- Reply to
CEO " We Believe The FDA Will Partner With Us To Get The Product To Patients Needing It" LINK
by tommyhill685 •May 9, 2013 10:12 AM5 stars
- Reply to
Interesting That SRPT CEO Would USE The Words " PARTNERING " WITH fda.
by mynameissteve258 •May 9, 2013 2:02 PMchris just told you..take a hint
- Reply to
When A CEO Says FDA Will " Partner " With Us, It's A BUY Signal.
by mdollarsigns •May 9, 2013 11:38 AM5 stars
-
couldnt agree more $
-
Yahoo News 5/9/13
Sarepta Therapeutics Announces First Quarter 2013 Financial Results and Recent Corporate Developments
Documents Requested by FDA for Accelerated Approval Consideration of Eteplirsen Will Be Submitted This Month; Clinical, Regulatory, and Manufacturing Activities Continue to Progress for Eteplirsen and Additional Duchenne Muscular Dystrophy Drug Candidates; Strong Cash Balance of $175 Million at Quarter-End